PEPG PepGen Inc.

Nasdaq pepgen.com


$ 4.91 $ -0.24 (-4.68 %)    

Thursday, 13-Nov-2025 15:59:55 EST
QQQ $ 608.18 $ -12.68 (-2.04 %)
DIA $ 475.16 $ -8.02 (-1.66 %)
SPY $ 672.38 $ -11.34 (-1.66 %)
TLT $ 89.46 $ -0.74 (-0.82 %)
GLD $ 383.38 $ -3.12 (-0.81 %)
$ 4.89
$ 5.03
$ 4.79 x 991
$ 5.25 x 10
$ 4.84 - $ 5.12
$ 0.88 - $ 6.85
439,620
na
352.68M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-24-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 06-16-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-pepgen-raises-price-target-to-20

HC Wainwright & Co. analyst Ananda Ghosh maintains PepGen (NASDAQ:PEPG) with a Buy and raises the price target from $18 ...

 hc-wainwright--co-maintains-buy-on-pepgen-raises-price-target-to-18

HC Wainwright & Co. analyst Ananda Ghosh maintains PepGen (NASDAQ:PEPG) with a Buy and raises the price target from $12 ...

 wedbush-maintains-outperform-on-pepgen-lowers-price-target-to-8

Wedbush analyst Laura Chico maintains PepGen (NASDAQ:PEPG) with a Outperform and lowers the price target from $9 to $8.

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

Core News & Articles

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...

 stifel-maintains-buy-on-pepgen-raises-price-target-to-12

Stifel analyst Paul Matteis maintains PepGen (NASDAQ: PEPG) with a Buy and raises the price target from $9 to $12.

 sp-500-falls-1-accenture-posts-upbeat-earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Thursday. The Dow traded ...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

 nasdaq-down-over-1-us-initial-jobless-claims-fall

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday. Following the market open...

 pepgen-reports-highest-splicing-correction-in-dystrophy-patients-stock-doubles

PepGen Inc. (NASDAQ: PEPG) stock is skyrocketing on Thursday, with a session volume of 53.04 million compared to the average vo...

 wedbush-maintains-outperform-on-pepgen-raises-price-target-to-9

Wedbush analyst Laura Chico maintains PepGen (NASDAQ: PEPG) with a Outperform and raises the price target from $7 to $9.

 crowdstrike-to-rally-around-26-here-are-10-top-analyst-forecasts-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

 hc-wainwright--co-maintains-buy-on-pepgen-raises-price-target-to-12

HC Wainwright & Co. analyst Ananda Ghosh maintains PepGen (NASDAQ: PEPG) with a Buy and raises the price target from $8 ...

 why-pepgen-shares-are-trading-higher-by-112-here-are-20-stocks-moving-premarket

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritt...

 accenture-stitch-fix-and-3-stocks-to-watch-heading-into-thursday

With U.S. stock futures trading mixed this morning on Thursday, some of the stocks that may grab investor focus today are as fo...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION